Recalling that they could not meet the commitment of exporting vaccines in the first quarter of 2021 due to "so much noise from public and the opposition", Poonawalla on Tuesday also pitched for a global pact for vaccine utilization
The company said it has received funding to initiate the Phase I and Phase II trials of an indigenous affordable Receptor-Binding Domain (RBD) based vaccine...
The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on...
